Varaico: Literature-Extracted Genetic Variants

Gene:CETP
Variant:p.L93L
Back to variants list

CETP

NM_000078.3:p.L93L

Associated Papers

Cholesteryl Ester Transfer Protein Deficiency and Hyperalphalipoproteinemia.

Inazu A

Journal of Atherosclerosis and Thrombosis, 2025

The impact of genetic variability on Alzheimer's therapies: obstacles for pharmacogenetic progress.

Cacabelos R et al.

Expert Opinion on Drug Metabolism & Toxicology, 2025

Association of RS708272 (CETP Gene Variant) with Lipid Profile Parameters and the Risk of Myocardial Infarction in the White Population of Western Siberia.

Semaev S et al.

Biomolecules, 2019

Genetic Risk Factors in Cerebrovascular Disorders and Cognitive Deterioration.

Carril JC et al.

Current Genomics, 2017

Population-based Study of Risk Polymorphisms Associated with Vascular Disorders and Dementia.

Teijido Ó et al.

Current Genomics, 2017

Prevalence of seven cardiovascular-related genetic polymorphisms in a Chilean mestizo healthy population.

Roco A et al.

Acta Cardiologica, 2015

CETP gene polymorphism in the caucasian population of West Siberia and in groups contrast by total serum cholesterol levels.

Shakhtshneider EV et al.

Bulletin of Experimental Biology and Medicine, 2014

Cholesterol ester transfer protein (CETP) gene polymorphism and selected parameters of lipid metabolism in children from families with history of cardiovascular system diseases.

Pac-Kożuchowska E et al.

Medical Science Monitor : International Medical Journal of Experimental and Clinical Research, 2013

High-density lipoprotein (HDL) particle subpopulations in heterozygous cholesteryl ester transfer protein (CETP) deficiency: maintenance of antioxidative activity.

Chantepie S et al.

Plos One, 2012

The impact of pharmacogenetics on HIV therapy.

Mahungu TW et al.

International Journal of Std & Aids, 2009

Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy.

Arnedo M et al.

Pharmacogenetics and Genomics, 2007

Toxicogenetics of antiretroviral therapy: genetic factors that contribute to metabolic complications.

Tarr PE et al.

Antiviral Therapy, 2007

Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese.

Nagano M et al.

Journal of Atherosclerosis and Thrombosis, 2004

Haplotype analyses of cholesteryl ester transfer protein gene promoter: a clue to an unsolved mystery of TaqIB polymorphism.

Lu H et al.

Journal of Molecular Medicine (berlin, Germany), 2003

Allele and genotype frequencies of polymorphic DCP1, CETP, ADRB2, and HTR2A in the Egyptian population.

Hamdy SI et al.

European Journal of Clinical Pharmacology, 2002

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."